Prosecution Insights
Last updated: November 04, 2026
Application No. 18/639,166

PENILE SLEEVE DEVICES AND METHODS OF MAKING THE SAME

Non-Final OA §103§112
Filed
Apr 18, 2024
Priority
May 20, 2019 — divisional of 10/517,730 +4 more
Examiner
HONRATH, MARC D
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Loria Cosmetic Urology LLC
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
8m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
109 granted / 149 resolved
+3.2% vs TC avg
Strong +34% interview lift
Without
With
+34.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
34 currently pending
Career history
189
Total Applications
across all art units

Statute-Specific Performance

§101
5.6%
-34.4% vs TC avg
§103
38.4%
-1.6% vs TC avg
§102
19.0%
-21.0% vs TC avg
§112
30.8%
-9.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 149 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Specification The lengthy specification has not been checked to the extent necessary to determine the presence of all possible minor errors. Applicant’s cooperation is requested in correcting any errors of which applicant may become aware in the specification. Claim Objections Claims 1-7 and 9-11 are objected to because of the following informalities: Claim 1, lines 15-16 recite “wherein said dorsal cuts, said ventral cuts and said lateral cuts avoiding or minimizing any buckling of the silicone material” but should read something similar to --wherein said dorsal cuts, said ventral cuts and said lateral cuts are configured to avoid or minimize any buckling of the silicone material-- for grammatical clarity. Claim 4, line 3, states “provided a desired thickness” but should read --provides a desired thickness--. Claims 5-7, line 1, recite “The penile sleeve” but should read --The penile sleeve device--. Claim 9, line 2, recites “that they do not” but should read --that the pair of longitudinal edges do not--. Claim 10, line 2, recites “such that it does not” but should read --such that the distal end does not--. Claim 11, line 2, recites “such that it does not” but should read --such that the proximal end does not--. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the subcutaneous layer" in line 1. There is insufficient antecedent basis for this limitation in the claim. Claim 1 recites the limitations "a plurality of cuts on a dorsal side", “a plurality of cuts on a ventral side”, and “each longitudinal edge has a plurality of lateral cuts therein”. While the dorsal and ventral cuts can be differentiated based on location, it is unclear from the claim how the “plurality of lateral cuts” is different from the dorsal or ventral cuts. It is unclear if the lateral cuts are intended to be considered part of the dorsal or ventral cuts. As such, the claim is indefinite. Claims 2-13 inherit the same deficiencies. Claim 2 recites the limitation "said distal end" in lines 1-2. There is insufficient antecedent basis for this limitation in the claim. Claim 3, line 2 recites “a non-dissolvable/absorbable bio-implantable netting/mesh material” which renders the claim indefinite because it is unclear if the “/” is intended to be “and” or “or”. Claims 4, 5, and 7 inherit the same deficiencies. Claim 12 recites the limitation "said distal end" in line 1. There is insufficient antecedent basis for this limitation in the claim. Claim 13, line 2 recites the limitation “such that longitudinal edges”. Claim 1 previously recited “a pair of longitudinal edges” so it is unclear if the limitation is referencing the pair of longitudinal edges in claim 1, rendering the claim indefinite. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1 and 9-13 are rejected under 35 U.S.C. 103 as being unpatentable over Cornell (US20200022812A1) and further in view of Loria (US9877835B1). Regarding claim 1, Cornell discloses a penile sleeve device configured for implantation in the subcutaneous space of a patient's penis for enhancing or correcting penis shape and size (Abstract), the penis having a glans, a penile shaft, penile dermis and an associated pubic area of the patient (Figure 14B), said penile sleeve device comprising an elongated member having a longitudinal axis (Figure 1) and formed of a bio-implantable reinforced silicon rubber (Paragraph [0032]), said elongated member having a distal portion comprising a C-shaped configuration (Figure 1 and Figure 4) and a pair of longitudinal edges (Figure 2), and said distal portion is configured for implantation on the patient's penile shaft adjacent the glans of the patient's penis and said proximal portion configured for implantation on the patient's penile shaft adjacent the pubic area of the patient (Paragraph [0048]), Cornell does not disclose said elongated member further comprising a plurality of cuts on a dorsal side thereof, said dorsal cuts being transverse to said longitudinal axis, a plurality of cuts on a ventral side thereof, said ventral cuts being transverse to said longitudinal axis; and wherein each longitudinal edge has a plurality of lateral cuts therein, said lateral cuts being transverse to said longitudinal axis (the limitation “wherein said dorsal cuts, said ventral cuts and said lateral cuts avoiding or minimizing any buckling of the silicone material in said penile sleeve device if the penis is ever rotated or twisted with said penile sleeve device implanted within the patient's penis” is interpreted as intended use). Loria discloses a penile insert device effective to prevent retraction of the penis and to increase the length of a penis in its flaccid or erect state (Abstract). Loria further discloses the insert device comprises a plurality of alternating lateral plateaus and lateral valleys (Abstract) which serve to provide for a bendable device that can move with the movement of the penis without causing discomfort to the user (Col 2, lines 14-15). As claim 1 of the instant application does not differentiate between the dorsal, ventral and lateral cuts, and the cuts of Loria are through both the dorsal and ventral sides of the device and reach the longitudinal sides of the implant, the cuts of Loria read on all three cuts, dorsal, ventral and lateral. It would have been obvious before the effective filing date of the claimed invention to one having ordinary skill in the art to modify the device as taught by Cornel, with the elongated member further comprising a plurality of cuts on a dorsal side thereof, said dorsal cuts being transverse to said longitudinal axis, a plurality of cuts on a ventral side thereof, said ventral cuts being transverse to said longitudinal axis; and wherein each longitudinal edge has a plurality of lateral cuts therein, said lateral cuts being transverse to said longitudinal axis as taught by Loria, since such a modification would provide the predictable results of a bendable device that can move with the movement of the penis without causing discomfort to the user (Loria, Col 2, lines 14-15). Regrading claims 9-11, Cornell, as modified by Loria, discloses the elongate edges to include distal and proximal portions have pillowed or rounded edges (Cornell, Paragraph [0048]). Regarding claim 12, Cornell, as modified by Loria, discloses said distal end comprises a tapered portion (Cornell, Figure 1). Regarding claim 13, Cornell, as modified by Loria, said elongated member comprises a lateral edge transition whereby said elongated member is curved such that longitudinal edges of said elongated member form a C-shaped cross-section profile (Cornell, Figures 3-6). Claim(s) 2, 3, 6, and 7 are rejected under 35 U.S.C. 103 as being unpatentable over Cornell (US20200022812A1) in view of Loria (US9877835B1), as applied to claim 1 and further in view of Elist (US20210361433A1). Regarding claim 2, Cornell as modified in claim 1, discloses mesh tabs located at the proximal and distal ends of the elongate body for the purpose of suturing the implant and promoting tissue ingrowth (Cornell, Paragraph [0049]) but fails to disclose a mesh surrounding said distal end of said elongated member for enhancing anchoring of said elongated member in the penile dermis. Elist discloses a genital implant enhancement device wherein the genital implant device comprises an elongated cylindrical sleeve that is configured to encircle a shaft of a penis (Abstract). Elist further discloses using a mesh layer as the external layer to the device in order to enable tissue ingrowth (Paragraph [0021]) wherein the mesh is configured to cover the distal end of the sleeve (Paragraph [0062]). It would have been obvious before the effective filing date of the claimed invention to one having ordinary skill in the art to modify the device as taught by modified Cornell, with a mesh surrounding the distal end of the elongated member for enhancing anchoring of said elongated member in the penile dermis as taught by Elist, since such a modification would provide the predictable results of better allowing the patient to acclimate to the device through tissue ingrowth (Elist, Paragraph [0021]). Regarding claim 3, modified Cornell, as further modified by Elist, further discloses said mesh cover includes a mesh layer comprising a non-dissolvable/absorbable bio-implantable netting/mesh material (Elist, Paragraph [0021]). Regarding claims 6 and 7, modified Cornell, as further modified by Elist, further discloses said mesh layer is coupled to said elongated member with dissolvable sutures (Elist, Paragraphs [0032], [0033]). Claim(s) 4 and 5 are rejected under 35 U.S.C. 103 as being unpatentable over Cornell (US20200022812A1) in view of Loria (US9877835B1) and Elist (US20210361433A1), as applied to claim 3, and further in view of Yachia (US4602625A). Regarding claim 4, modified Cornell does not disclose said mesh cover further comprises at least one silicone sheet coupled to said mesh layer, said at least one silicone sheet comprising silicone sheeting material that is non-reinforced, said at least one silicone sheet provided a desired thickness to said mesh cover. Yachia discloses a penile erectile system for treating male impotency comprising a sleeve of biocompatible material (Abstract) wherein the sleeve is encased in a smooth outer cover of silicone coated mesh (Col 3, lines 61-64, Figure 1, “27”). The coating of silicone can be interpreted as layer or sheet of silicone and the coating would be non-reinforced before it is coupled to the mesh. The coupled mesh and silicone would provide a desired thickness by design. It would have been obvious before the effective filing date of the claimed invention to one having ordinary skill in the art to modify the device as taught by modified Cornell, with a mesh cover that further comprises at least one silicone sheet coupled to said mesh layer, said at least one silicone sheet comprising silicone sheeting material that is non-reinforced, said at least one silicone sheet provided a desired thickness to said mesh cover as taught by Yachia, since such a modification would provide the predictable results of controlled elasticity (Col 3, lines 61-64). Regarding claim 5, Cornell, as modified by Loria and Elist, disclosed the mesh cover is coupled to the elongate member with sutures in claim 6 supra. As Cornell, modified in claim 4 by Yachia, discloses the silicone coats the mesh, as the mesh is sutured to the elongated member, the silicone would also be coupled to the mesh via suture. Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over Cornell (US20200022812A1) in view of Loria (US9877835B1), as applied to claim 1 and further in view of Dubernard (FR 3074416 A1). Regarding claim 8, Cornell, as modified in claim 1, discloses the penile sleeve device has a durometer Shore A of up to about 70 (Paragraph [0034]) but does not disclose a Shore A of 80. Dubernard discloses a penile implant (Abstract) comprising a component for implantation into the penis (Page 3), wherein the component comprises a polymeric material, specifically polysiloxane polymer, with a durometer of Shore A up to 90 (Page 3). It would have been obvious before the effective filing date of the claimed invention to one having ordinary skill in the art to modify the device as taught by modified Cornell, said elongated member comprising a durometer of Shore 80A as taught by Dubernard, since such a modification would provide the predictable results of providing adequate structure to the sleeve device. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Marc D Honrath whose telephone number is (571)272-6219. The examiner can normally be reached M-F 7:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Charles A Marmor II can be reached at (571) 272-4730. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHARLES A MARMOR II/Supervisory Patent Examiner Art Unit 3791 /M.D.H./Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Apr 18, 2024
Application Filed
Oct 28, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758792
METHOD FOR ESTIMATING A TOTAL SCATTER FACTOR IN DOSE CALCULATION FOR RADIOTHERAPY
4y 6m to grant Granted Oct 13, 2026
Patent 12751882
METHODS AND SYSTEMS FOR PROVIDING OPEN ACCESS POINT INDICATORS IN AN INFANT CARE STATION
4y 4m to grant Granted Oct 06, 2026
Patent 12727903
IMPLANTABLE CHANNEL GUIDES AND METHODS AND KITS THEREOF
4y 1m to grant Granted Sep 08, 2026
Patent 12702609
HYPERBARIC OXYGEN THERAPY (HBOT) CALIBRATIONS BASED ON IN-CHAMBER BRAINWAVE METRICS
2y 3m to grant Granted Aug 11, 2026
Patent 12697135
THREADING SUPPORT FACILITY FOR THREADING AN OBJECT INTO A GUIDE APPARATUS
5y 2m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+34.0%)
3y 2m (~8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 149 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month